|
| Author/year | Device type/brand | No. of subjects | Significant findings |
|
| Studies on normal eyes only |
| Shen et al. 2013 [56] | RTVue (SD-OCT) and CB-OCT (UHR-OCT) | NL: 18 | ICC:
CB-OCT: 0.82–0.97
RTVue: 0.78–0.92
(Higher repeatability toward the center) |
| Kanellopoulos and Asimellis 2013 [57] | RTVue (SD-OCT) | NL: 373 | SW: 0.88 ± 0.71 μm in the center |
| Wasielica-Poslednik et al. 2015 [58] | RTVue (SD-OCT) | NL: 23 | ICC: 0.780–0.952 |
| Beer et al. 2018 [59] | CB PS-OCT | NL: 20 | WCV ≤3%
(Very good repeatability) |
| Hashmani et al. 2022 [60] | RTVue (SD-OCT) | NL: 220 | ICC:
Inner circle: 0.703–0.812
Middle circle: 0.712–0.917
Outer circle: 0.796–0.930
(Good-to-excellent reproducibility) |
| Sikorski 2022 [48] | REVO NX, Optopol (SD-OCT) | NL: 137 | ICC: 0.64–0.95
(Higher repeatability toward the center) |
|
| Studies on post-LRS eyes ± normal eyes |
| Reinstein et al. 2010 [23] | Artemis VHF-US | Post-LASIK: 10 | SW:
0.58 μm at the corneal vertex
0.43–1.36 μm at the central 6 mm |
| Ge et al. 2013 [41] | RTVue (SD-OCT), Visante (TD-OCT), and 2 CB-OCT devices (UHR-OCT and UL-OCT) | NL: 20
Post-LASIK: 18 | ICC: >0.84
SW:
<2.2 μm in NL
<4.8 μm in post-LASIK
(Higher optical resolution ∼ better repeatability) |
| Ma et al. 2013 [61] | RTVue (SD-OCT) | NL: 35
Post-LASIK: 45 | ICC:
≥0.917 in normal
≥0.891 in post-LASIK |
| Ryu et al. 2017 [62] | RTVue (SD-OCT) | Post-FS-LASIK: 62
Post-SMILE: 113 | SW:
0.8 μm at center
1.2–1.5 μm at midperiphery
(Higher repeatability toward the center) |
| Sedaghat et al. 2018 [63] | RTVue (SD-OCT) | Pre and post-PRK: 52 | SW:
1.73 μm pre-PRK
4.50 μm 6 months post-PRK |
| Latifi and Mohammadi 2020 [52] | RTVue (SD-OCT) (6 mm vs. 9 mm scan) | Myopic: 95
Post-PRK: 117 | WCV:
In 6 mm scan:
<3.08% (myopic) and <4.80% (post-PRK)
In 9 mm scan:
<5.14% (myopic) and <5.18% (post-PRK) |
|
| Studies on eyes with ocular surface disorders ± post-LRS or normal eyes |
| Li et al. 2012 [7] | RTVue (SD-OCT) | NL: 75
KCN: 35 | SW:
0.7 μm in NL
1.0 μm in KCN (at central 2 mm) |
| Kanellopoulos and Asimellis 2014 [64] | RTVue (SD-OCT) | NL: 160
KCN: 160 | SW:
0.89 μm in NL
1.78 μm in KCN (at central 2 mm) |
| Ma et al. 2018 [65] | RTVue-XR (SD-OCT) | NL: 12
CL user: 12
DED: 11
Post-PRK/LASIK: 12
KCN: 14 | SW:
≤2.6 μm in all groups
0.7–1.5 μm in NL
1.0–2.6 μm in CL users
0.9–2.0 μm in DED
0.7–2.5 μm in post-PRK/LASIK
1.1–2.3 μm in KCN (highest in inferior peripheral zones, except for KCN eyes) |
| Sella et al. 2018 [66] | RTVue (SD-OCT) | NL: 12
CL user: 12
DED: 12
Post-LRS: 12
KCN: 12 | SW:
0.9 μm in NL
1.2 μm in eye with corneal conditions (at central 2 mm)
Similar repeatability in all groups, except DED eyes with lower repeatability (2.0 and 2.4 μm in superior and inferior 2–5 mm ring for DED vs. 0.8–1.3 and 0.8–1.1 μm for other groups); an inverse correlation with DED severity was suggested |
| Vega-Estrada et al. 2019 [46] | MS-39 | NL: 60
KCN: 107 | SW:
1.24 μm in NL
2.03 μm in KCN (at central 3 mm) |
| Lu et al. 2019 [67] | RTVue-XR (SD-OCT) | NL (myopic): 75
Post-PRK: 68
Post-SMILE: 61
Post-LASIK: 75
Mild KCN: 20
Advanced KCN: 53 | WCV:
1.7–3.5% in NL (myopic)
2.3–6.3% in post-LRS
2.5–6.2% in mild KCN
3.5–8.0% in advanced KCN
(More variable in post-LRS and KCN eyes) |
| Mohr et al. 2020 [68] | RTVue-XR (SD-OCT) | KCN: 59
PMD: 10 | ICC:
0.827–0.986 in KCN
0.753–0.998 in PMD
(Reduced repeatability toward the periphery) |
| Li et al. 2021 [69] | REVO NX, Optopol SD-OCT | KCN ± CXL: 212 | ICC:
>0.86 in KCN/CXL−
>0.83 in KCN/CXL+ |
| Schiano-Lomoriello et al. 2022 [70] | MS 39 SD-OCT | KCN: 44 | WCV < 5% (for central CET) |
| Feng et al. 2022 [43] | Anterion SS-OCT and Avanti SD-OCT | NL: 90
KCN: 122
Post-LRS: 46 | SW:
By Anterion:
0.88 (NL), 1.08 (post-LRS), 1.26 (KCN) μm
By Avanti:
1.12 (NL), 1.62 (post-LRS), 1.52 (KCN) μm
(In 0–7 mm area)
(Anterion was superior) |
|
